Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Fallopian Tube Neoplasms × Fulvestrant × Clear all

Sponsor

Conditions

Breast Neoplasms 93 Neoplasms 12 Neoplasm Metastasis 12 Hereditary Sensory and Autonomic Neuropathies 3 Advanced Breast Cancer 3 Recurrence 2 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Multiple Endocrine Neoplasia Type 1 2 Endometrial Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms, Male 2 Solid Malignancies 1 Recurrent Uterine Corpus Carcinoma 1 Neoplasms by Site 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Lethal Congenital Contracture Syndrome 2 1 Hyperglycemia 1 Hormone Receptor Positive HER-2 Negative Breast Cancer 1 Hormone Receptor Positive Breast Cancer 1 HER2-positive Breast Cancer 1 Exanthema 1 Estrogen Receptor-positive Breast Cancer 1 Carcinoma, Ovarian Epithelial 1 Breast Diseases 1 Breast Cancer Metastatic 1 Anatomic Stage IV Breast Cancer AJCC v8 1 Advanced Metastatic Breast Cancer 1 Advanced Cancer 1

Interventions

Paclitaxel 49 Carboplatin 47 Bevacizumab 35 Taxes 22 liposomal doxorubicin 18 Gemcitabine 16 pembrolizumab 14 Immunoglobulin G 14 Disulfides 14 Topotecan 10 Cisplatin 9 rucaparib 8 olaparib 7 Docetaxel 7 Cyclophosphamide 7 mirvetuximab soravtansine 6 cediranib 6 Magnetic Resonance Spectroscopy 6 Doxorubicin 6 pazopanib 5 Specimen Handling 5 Nivolumab 5 sargramostim 4 niraparib 4 Surgical Procedures, Operative 4 Cytoreduction Surgical Procedures 4 Albumin-Bound Paclitaxel 4 fludarabine phosphate 3 belinostat 3 avelumab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡